AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24557758 — intervention group
Group type: COMPARATOR
Intervention: Eyedrops (tropicamide 1% and phenylephrine 10%)
Number of subjects: 77
Study 24557758 — intervention group
Group type: EXPERIMENTAL
Intervention: Mydriasert and Eyedrops (both groups)
Number of subjects: 77
Study 22089379 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir (400 mg twice/day)
Number of subjects: 24
Study 22089379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 19515124 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (1 Hz, two trains of 500 pulses)
Number of subjects: 27
Study 19515124 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham coil)
Number of subjects: 27
Study 17329700 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 1
Study 15237059 — intervention group
Group type: EXPERIMENTAL
Intervention: Color-coded method
Number of subjects: 101
Study 15237059 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 101
Study 12030642 — intervention group
Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated)
Number of subjects: 0
Study 9495425 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 2.5 mg (Group G)
Number of subjects: 150
Study 8741025 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 16
Study 8741025 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 16
Study 8741025 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 16
Study 2258249 — intervention group
Group type: EXPERIMENTAL
Intervention: SR nicardipine (40 mg b.i.d.)
Number of subjects: 36
Study 2258249 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (25 mg once daily)
Number of subjects: 36
Study 2258249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 7015846 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal
Number of subjects: 0
Study 7015846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31617468 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative implementation intentions (IIs)
Number of subjects: 80
Study 27830643 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator-based occupational therapy driving intervention (OT-DI); 3 sessions addressing driving errors and visual-search retraining
Number of subjects: 26
Study 27830643 — intervention group
Group type: COMPARATOR
Intervention: Traffic safety education (TSE); 3 sessions addressing personal factors and defensive driving
Number of subjects: 26
Study 25330085 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-graded protocol
Number of subjects: 20
Study 25330085 — intervention group
Group type: COMPARATOR
Intervention: Long-graded protocol
Number of subjects: 20
Study 25330085 — intervention group
Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 20
Study 24809482 — intervention group
Group type: COMPARATOR
Intervention: Group S (shallow block) with rocuronium 0.45 mg kg-1
Number of subjects: 102
Study 24809482 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D (deep block) with rocuronium 0.6 mg kg-1
Number of subjects: 102
Study 24809482 — intervention group
Group type: COMPARATOR
Intervention: Comparison of surgical field scores between groups S and D
Number of subjects: 102
Study 23041997 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano Foam cleaner
Number of subjects: 20
Study 23041997 — intervention group
Group type: COMPARATOR
Intervention: ProFile File cleaner
Number of subjects: 20
Study 20379032 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold polymerized soft liner (Visco Gel)
Number of subjects: 32
Study 20379032 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat polymerized soft liner (Molloplast B)
Number of subjects: 32
Study 17524123 — intervention group
Group type: EXPERIMENTAL
Intervention: New 4% hydroquinone cream
Number of subjects: 0
Study 17524123 — intervention group
Group type: COMPARATOR
Intervention: Commercial 4% hydroquinone creams
Number of subjects: 0
Study 17524123 — intervention group
Group type: COMPARATOR
Intervention: 4% hydroquinone product with 0.05% tretinoin and 0.01% fluocinolone acetonide
Number of subjects: 0
Study 16253600 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg/day (n = 48)
Number of subjects: 91
Study 16253600 — intervention group
Group type: COMPARATOR
Intervention: no lipid-lowering treatment (n = 43)
Number of subjects: 91
Study 11876795 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MU of IFN-alpha thrice weekly for 24 weeks
Number of subjects: 165
Study 11876795 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced regimen for 48 weeks
Number of subjects: 165
Study 11876795 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonresponders and relapsers)
Number of subjects: 165
Study 10633742 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Nursing implemented in group 1 (two nursing units) after t1
Number of subjects: 0
Study 10633742 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Nursing implemented in group 2 (three nursing units) after t2
Number of subjects: 0
Study 10633742 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention period (t1)
Number of subjects: 0
Study 10633742 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention period (t2, 8 months after t1)
Number of subjects: 0
Study 10633742 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention period (t3, 14 months after t1)
Number of subjects: 0
Study 7572740 — intervention group
Group type: EXPERIMENTAL
Intervention: high-linoleic acid margarine
Number of subjects: 27
Study 7572740 — intervention group
Group type: EXPERIMENTAL
Intervention: high-palm oil margarine
Number of subjects: 27
Study 7572740 — intervention group
Group type: EXPERIMENTAL
Intervention: high-palm oil margarine (interesterified)
Number of subjects: 27
Study 1690551 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ribavirin 600 mg
Number of subjects: 164
Study 1690551 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ribavirin 800 mg
Number of subjects: 164
Study 1690551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 42523 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg cimetidine
Number of subjects: 17
Study 42523 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg cimetidine and 50 mg methanthelinebromide
Number of subjects: 17
Study 42523 — intervention group
Group type: COMPARATOR
Intervention: 50 mg methanthelinebromide
Number of subjects: 17
Study 31416768 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBVAC (5×10^5 CFU in 0.1 mL)
Number of subjects: 54
Study 31416768 — intervention group
Group type: COMPARATOR
Intervention: BCG Vaccine SSI (5×10^5 CFU in 0.1 mL)
Number of subjects: 54
Study 31416768 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBVAC (2.5×10^3 CFU in 0.05 mL)
Number of subjects: 54
Study 31416768 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBVAC (2.5×10^4 CFU in 0.05 mL)
Number of subjects: 54
Study 31416768 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBVAC (2.5×10^5 CFU in 0.05 mL)
Number of subjects: 54
Study 31416768 — intervention group
Group type: COMPARATOR
Intervention: BCG Vaccine SSI (2.5×10^5 CFU in 0.05 mL)
Number of subjects: 54
Study 28333185 — intervention group
Group type: EXPERIMENTAL
Intervention: Steiner-Tan Needle® flushing system (n = 40)
Number of subjects: 80
Study 28333185 — intervention group
Group type: COMPARATOR
Intervention: Single-lumen aspiration needle (Gynetics®) (n = 40)
Number of subjects: 80
Study 25771480 — intervention group
Group type: EXPERIMENTAL
Intervention: Static and dynamic orthoses
Number of subjects: 60
Study 25771480 — intervention group
Group type: COMPARATOR
Intervention: Other hand therapy treatments (control)
Number of subjects: 60
Study 22561230 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg once daily for 24 weeks
Number of subjects: 19
Study 22561230 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 80 mg once daily for 24 weeks
Number of subjects: 19
Study 21739699 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupotomy
Number of subjects: 105
Study 21739699 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture
Number of subjects: 105
Study 21739699 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 105
Study 19608993 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator
Number of subjects: 965
Study 19608993 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline antiplatelet use (single antiplatelet)
Number of subjects: 965
Study 19608993 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline antiplatelet use (double antiplatelet)
Number of subjects: 965
Study 19608993 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher National Institutes of Health Stroke Scale score
Number of subjects: 965
Study 19608993 — intervention group
Group type: EXPERIMENTAL
Intervention: CT changes defined by ASPECTS (ASPECTS < or =7)
Number of subjects: 965
Study 16499476 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg, orally, three times a day for 2 days)
Number of subjects: 6
Study 16499476 — intervention group
Group type: COMPARATOR
Intervention: Placebo (orally, three times a day for 2 days)
Number of subjects: 6
Study 15005740 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 10
Study 15005740 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide
Number of subjects: 10
Study 15005740 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 10
Study 15005740 — intervention group
Group type: COMPARATOR
Intervention: Reversed osmosis water (control)
Number of subjects: 10
Study 12521832 — intervention group
Group type: EXPERIMENTAL
Intervention: 17‐beta oestradiol 25‐mg vaginal tablets
Number of subjects: 110
Study 12521832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 9773136 — intervention group
Group type: EXPERIMENTAL
Intervention: Very slow injection of local anaesthetic (injection time 100 to 150 seconds, Group A)
Number of subjects: 75
Study 9773136 — intervention group
Group type: COMPARATOR
Intervention: Faster injection of local anaesthetic (injection time 40 to 80 seconds, Group B)
Number of subjects: 75
Study 9623464 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based learning package
Number of subjects: 84
Study 9623464 — intervention group
Group type: COMPARATOR
Intervention: Control group (no access to computer material)
Number of subjects: 84
Study 9623464 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (computer and control)
Number of subjects: 84
Study 2923077 — intervention group
Group type: EXPERIMENTAL
Intervention: High P:S diet (P:S 1.0)
Number of subjects: 14
Study 600190 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol (5 mg to 20 mg) with hydrochlorothiazide
Number of subjects: 65
Study 600190 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide alone
Number of subjects: 65
Study 600190 — intervention group
Group type: EXPERIMENTAL
Intervention: Moduretic (hydrochlorothiazide, 50 mg and amiloride, 5 mg) with timolol
Number of subjects: 65
Study 600190 — intervention group
Group type: COMPARATOR
Intervention: Moduretic alone
Number of subjects: 65
Study 31638920 — intervention group
Group type: COMPARATOR
Intervention: Control group participants in a randomized controlled trial (specific intervention details not provided)
Number of subjects: 0
Study 28729250 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB (Drug-Coated Balloon)
Number of subjects: 300
Study 28729250 — intervention group
Group type: COMPARATOR
Intervention: PTA (Percutaneous Transluminal Angioplasty)
Number of subjects: 300
Study 29083391 — intervention group
Group type: EXPERIMENTAL
Intervention: Maitland mobilization and lumbar stabilization exercises
Number of subjects: 30
Study 29083391 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (traction, strengthening, stretching exercises)
Number of subjects: 30
Study 23284039 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete resection before chemotherapy
Number of subjects: 278
Study 23284039 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete resection before chemotherapy
Number of subjects: 278
Study 23284039 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy or no surgery before chemotherapy
Number of subjects: 278
Study 23284039 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete resection after induction chemotherapy
Number of subjects: 278
Study 23284039 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete resection after induction chemotherapy
Number of subjects: 278
Study 23284039 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy or no surgery after induction chemotherapy
Number of subjects: 278
Study 21440999 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 393
Study 21440999 — intervention group
Group type: COMPARATOR
Intervention: Standard Treatment (ST)
Number of subjects: 393
Study 18851852 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (2 g of elemental calcium)
Number of subjects: 524
Study 18851852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 524
Study 16728220 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiographic adverse events during PCI
Number of subjects: 6010
Study 16728220 — intervention group
Group type: EXPERIMENTAL
Intervention: Occurrence of angiographic adverse events
Number of subjects: 6010
Study 16728220 — intervention group
Group type: EXPERIMENTAL
Intervention: Side branch closure, abrupt closure, decreased flow, distal embolization, perforation or tamponade
Number of subjects: 6010
Study 16281880 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg isotretinoin + 0.05% tretinoin cream
Number of subjects: 28
Study 16281880 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg isotretinoin + 0.05% tretinoin cream
Number of subjects: 28
Study 16281880 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg isotretinoin/kg bodyweight + 0.05% tretinoin cream + oral methylprednisolone
Number of subjects: 28
Study 16281880 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg isotretinoin/kg bodyweight + 0.05% tretinoin cream
Number of subjects: 28
Study 11724639 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (8 mg acute, titrated to 16 mg daily chronic)
Number of subjects: 21
Study 11724639 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (chronic)
Number of subjects: 21
Study 11724639 — intervention group
Group type: COMPARATOR
Intervention: Candesartan (acute and chronic)
Number of subjects: 21
Study 9390536 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 2306
Study 9390536 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate, fluorouracil, and tamoxifen (MFT)
Number of subjects: 2306
Study 9390536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate, fluorouracil, and tamoxifen (CMFT)
Number of subjects: 2306
Study 8203874 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 hours of bed rest post-cardiac catheterization
Number of subjects: 0
Study 8203874 — intervention group
Group type: COMPARATOR
Intervention: 6 hours of bed rest post-cardiac catheterization
Number of subjects: 0
Study 2658575 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS-201-995
Number of subjects: 11
Study 2658575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 31482417 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin 2.5 mg/kg every 12 hours (Group 1)
Number of subjects: 56
Study 31482417 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin 4 mg/kg every 36 hours (Group 2)
Number of subjects: 56
Study 31482417 — intervention group
Group type: COMPARATOR
Intervention: No Gentamicin therapy (Group 3)
Number of subjects: 56
Study 28279833 — intervention group
Group type: EXPERIMENTAL
Intervention: Mipomersen 200 mg sc weekly for 26 weeks
Number of subjects: 15
Study 28279833 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mipomersen)
Number of subjects: 15
Study 25576052 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation
Number of subjects: 30
Study 25576052 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study 23466551 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-stigma films (intervention group)
Number of subjects: 43
Study 23466551 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 43
Study 21736454 — intervention group
Group type: EXPERIMENTAL
Intervention: High-confidence trials during source memory task (MTL region)
Number of subjects: 0
Study 21736454 — intervention group
Group type: EXPERIMENTAL
Intervention: High-confidence trials during item memory task (MTL region)
Number of subjects: 0
Study 21736454 — intervention group
Group type: EXPERIMENTAL
Intervention: Source memory tasks (PFC region)
Number of subjects: 0
Study 21736454 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-confidence activity in both tasks (PFC region)
Number of subjects: 0
Study 21736454 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-confidence activity (Parietal region)
Number of subjects: 0
Study 21736454 — intervention group
Group type: EXPERIMENTAL
Intervention: High-confidence activity (Parietal region)
Number of subjects: 0
Study 18647298 — intervention group
Group type: EXPERIMENTAL
Intervention: fesoterodine 8 mg
Number of subjects: 0
Study 18647298 — intervention group
Group type: EXPERIMENTAL
Intervention: tolterodine ER 4 mg
Number of subjects: 0
Study 18647298 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 16225841 — intervention group
Group type: EXPERIMENTAL
Intervention: Task Concentration Training (TCT)
Number of subjects: 65
Study 16225841 — intervention group
Group type: EXPERIMENTAL
Intervention: Task Concentration Training (TCT) combined with Cognitive Therapy (CT)
Number of subjects: 65
Study 16225841 — intervention group
Group type: EXPERIMENTAL
Intervention: Task Concentration Training (TCT) or TCT-CT
Number of subjects: 65
Study 16225841 — intervention group
Group type: COMPARATOR
Intervention: Applied Relaxation (AR)
Number of subjects: 65
Study 12629444 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-week exercise and diet program
Number of subjects: 14
Study 12629444 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued exercise training at home for seven adolescents
Number of subjects: 14
Study 12629444 — intervention group
Group type: COMPARATOR
Intervention: Diet alone (control group)
Number of subjects: 14
Study 10718895 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (3-hour 'train-a-trainer' workshop)
Number of subjects: 0
Study 10718895 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-only group (mailed nutrition manual)
Number of subjects: 0
Study 10718895 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 8885210 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal trainer intervention (regular calls and scheduled walks)
Number of subjects: 0
Study 8885210 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery incentive for exercise adherence
Number of subjects: 0
Study 8885210 — intervention group
Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 0
Study 1545669 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-DOTA (0.1 mmol/kg)
Number of subjects: 20
Study 1545669 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Gd-DOTA)
Number of subjects: 20
Study 4045017 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training program (30-minute continuous walk/jog, 3 days/week at 70-85% heart rate)
Number of subjects: 36
Study 4045017 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training program
Number of subjects: 36
Study 4045017 — intervention group
Group type: COMPARATOR
Intervention: Control group (sedentary)
Number of subjects: 36
Study 30211752 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanistic Concept Maps (MCMs) intervention (n = 43)
Number of subjects: 170
Study 30211752 — intervention group
Group type: COMPARATOR
Intervention: Control groups (n = 127)
Number of subjects: 170
Study 28464491 — intervention group
Group type: EXPERIMENTAL
Intervention: No IDUC
Number of subjects: 131
Study 28464491 — intervention group
Group type: COMPARATOR
Intervention: IDUC
Number of subjects: 131
Study 27504532 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) applied to one side of the jaw
Number of subjects: 20
Study 27504532 — intervention group
Group type: COMPARATOR
Intervention: Peripheral blood (PB)
Number of subjects: 20
Study 27504532 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular bone marrow with ESWT (BM + SW)
Number of subjects: 20
Study 27504532 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular bone marrow without ESWT (BM - SW)
Number of subjects: 20
Study 24694746 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 kcal per session
Number of subjects: 92
Study 24694746 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 kcal per session
Number of subjects: 92
Study 24694746 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 92
Study 22666779 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer lactate (group RL)
Number of subjects: 75
Study 22666779 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) (130/0.4) (group HES)
Number of subjects: 75
Study 22666779 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% succinylated gelatin (gelofusine solution) (group JEL)
Number of subjects: 75
Study 20173364 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guérin (BCG)
Number of subjects: 64
Study 20173364 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine
Number of subjects: 64
Study 18548234 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-mg transdermal nicotine patch
Number of subjects: 22
Study 18548234 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 22
Study 15709546 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral immunonutrition for 5 days
Number of subjects: 0
Study 15709546 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (no supplementation)
Number of subjects: 0
Study 12408922 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation R (400 mg)
Number of subjects: 6